Patents Assigned to Foundation
  • Patent number: 8142708
    Abstract: Laminar flow of a carrier liquid and polymeric molecules through micro-channels is used to straighten the polymeric molecules and attach the straightened molecules to a wall of the micro-channel for subsequent treatment and analysis. Micro-channels can be manufactured using an elastic molding material. One micro-channel embodiment provides fluid flow using a standard laboratory centrifuge.
    Type: Grant
    Filed: October 18, 2002
    Date of Patent: March 27, 2012
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: David C. Schwartz, Eileen T. Dimalanta, Juan J. de Pablo
  • Patent number: 8143085
    Abstract: Provided is a dye-sensitized solar cell. Specifically, the present invention provides a dye-sensitized solar cell which is designed to reduce the production cost, improve productivity and increase energy efficiency by using a carbon electrode as a counter electrode, and a manufacturing method thereof. The dye-sensitized solar cell according to the present invention is characterized by comprising a working electrode, a counter electrode, and an electrolytic layer separating the two electrodes, wherein the counter electrode comprises a carbon electrode formed on a first transparent substrate, wherein the carbon electrode is a conductive transparent carbon electrode. According to the present invention, it is possible to remarkably reduce the production cost by using a relatively low-cost material, i.e. carbon electrode, and improve the solar cell efficiency by preventing oxidation with the electrolytic layer owing to corrosion and oxidation resistance of the carbon electrode.
    Type: Grant
    Filed: January 29, 2009
    Date of Patent: March 27, 2012
    Assignee: Sungkyunkwan University Foundation For Corporate Collaboration
    Inventors: Byung You Hong, Yong Seob Park, Sung Uk Lee, Mi Ju Park
  • Patent number: 8142890
    Abstract: Compositions and methods for fabrication or synthesis of high aspect ratio (up to >150) CdS:Mn/ZnS core/shell nanowires (CSNWs) is disclosed for the first time. The CSNW solvothermal synthesis involved two steps—the formation of Mn doped CdS core followed by the growth of a ZnS outer shell. The nanowire growth process is engineered in such a way that the ZnS layer grows radially onto the prematurely grown CdS:Mn core prior to the formation of its well faceted surface. Transmission electron microscopy (TEM) and other characterization techniques confirmed the formation of uniform, thin (5-8 nm in diameter) CSNWs with high aspect ratio up to >150. This solvothermal method is simple, versatile and useful in a large scale production process to synthesize thin ultra-long CSNWs with and without dopants.
    Type: Grant
    Filed: December 4, 2008
    Date of Patent: March 27, 2012
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Soumitra Kar, Swadeshmukul Santra
  • Publication number: 20120071664
    Abstract: Disclosed are ?-amino acids that are unsubstituted in the ? position; that are substituted in the ? position with an aryl group; that are substituted in the ? position with an aryl group; that bear two substituents in the ? position; and/or that are substituted in the ? and ? positions with groups which, together with the carbon atoms at the ? and ? positions, form a ring. Also disclosed are methods for making the above-mentioned ?-amino acids and other ?-amino acids which involve providing an ?,?-unsaturated imide; converting the ?,?-unsaturated imide to a 2-substituted-isoxazolidin-5-one; and converting the 2-substituted-isoxazolidin-5-one to a ?-amino acid.
    Type: Application
    Filed: September 20, 2011
    Publication date: March 22, 2012
    Applicant: NDSU Research Foundation
    Inventors: Mukund P. SIBI, Craig P. Jasperse, Prabagaran Narayanasamy, Sandeep R. Ghorpade
  • Publication number: 20120071356
    Abstract: Methods for identifying a subject at risk for developing AMD are disclosed, as are kits which can be used to practice the methods. The methods include identifying specific protective or risk polymorphisms or genotypes from the subject's genetic material, including polymorphisms in the BF, C2 and/or CFH genes. Microarrays and kits for use in these methods are also provided.
    Type: Application
    Filed: August 2, 2011
    Publication date: March 22, 2012
    Applicants: University of Iowa Research Foundation, National Institutes of Health, The Trustees of Columbia University in The City of New York
    Inventors: Rando L. Allikmets, Gregory S. Hageman, Michael C. Dean, Albert M. Gold
  • Publication number: 20120071987
    Abstract: Stents, kits and methods of using the stents are described herein. The stents may include one or more features that assist in removal and/or retrieval of the stent after deployment.
    Type: Application
    Filed: March 24, 2011
    Publication date: March 22, 2012
    Applicant: Mayo Foundation for Medical Education and Research
    Inventor: Michael J. Levy
  • Publication number: 20120069751
    Abstract: A mobile terminal and a handover method for the mobile terminal are disclosed. A mobile terminal according to an embodiment of the invention may include: a communication unit configured to receive from a base station multiple frames, each belonging to one of two or more frame in a set order of priority; and a control unit configured to control the mobile terminal to perform a handover to a base station based on the occurrence pattern of frame types of the multiple frames.
    Type: Application
    Filed: May 23, 2011
    Publication date: March 22, 2012
    Applicant: Chung-Ang University Industry-Academy Cooperation Foundation
    Inventors: Jung-Ryun Lee, Hyun-Sik Kang
  • Publication number: 20120070490
    Abstract: The present invention provides methods of killing, inhibiting the growth, and/or inhibiting the reproduction of kinetoplastid protozoan with hydrophobic signal sequence peptides and compositions including such hydrophobic signal sequence peptides.
    Type: Application
    Filed: October 27, 2011
    Publication date: March 22, 2012
    Applicant: University of Georgia Research Foundation, Inc.
    Inventors: John M. Harrington, Stephen L. Hajduk
  • Publication number: 20120071344
    Abstract: The invention is directed to compositions, e.g., cell-based and multiplexed platforms, to screen for small molecule drugs that inhibit enzymes such as proteases, e.g., viral proteases, e.g., HIV proteases; and methods for making and using these compositions. The invention provides compositions and methods for identifying compositions, e.g., drug molecules, that can inhibit proteases, e.g., viral proteases such as HIV proteases. In alternative embodiments, the invention provides cell-based platforms or assays to screen for compositions, e.g., small molecules or drugs, that inhibit or modify the activity of enzymes such as calcium-dependent protein convertases involved in HIV envelope protein processing, including cleavage of the HIV gp160 envelope precursor, resulting in gp120 and gp41 envelope products. In one embodiment, the invention provides a cell-based or multiplexed platform for monitoring the activity of enzymes, e.g., proteases such as viral proteases.
    Type: Application
    Filed: September 21, 2011
    Publication date: March 22, 2012
    Applicants: dba San Diego State University (SDSU) Research Foundation, San Diego State University (SDSU) Foundation, dba
    Inventor: Roland WOLKOWICZ
  • Publication number: 20120069301
    Abstract: A sleepiness sign detection apparatus, includes: a head movement detection unit configured to detect a head movement to generate a head movement data; an eye movement detection unit configured to detect an eye movement to generate an eye movement data; an ideal eye movement angular velocity calculation unit configured to calculate an ideal eye movement angular velocity based on the head movement data generated by the head movement detection unit; an eye-rotation angular velocity calculation unit configured to calculate an eye-rotation angular velocity based on the eye movement data generated by the eye movement detection unit; and a sleepiness sign detection unit configured to detect vestibule-ocular reflex (VOR) from the ideal eye movement angular velocity and the eye-rotation angular velocity, and determine a sign of sleepiness based on the vestibule-ocular reflex.
    Type: Application
    Filed: March 17, 2011
    Publication date: March 22, 2012
    Applicant: Chubu University Educational Foundation
    Inventor: Yutaka Hirata
  • Publication number: 20120071553
    Abstract: A combination of the surfactant SDS with levulinic acid produces a synergistic effect in relation to the antimicrobial effectiveness of the individual compounds, allowing the formulation of compositions wherein the active agents are present at concentrations effective to reduce bacterial and fungal counts in liquids, including, but not limited to, water and other beverages, without altering the organoleptic properties of the treated food substance. The active agents are FDA-approved as food additives, and the treated beverages can be any aqueous-based beverage consumable by humans or animals. The levulinic acid-SDS combination is also suitable for reducing or eliminating the microbial population on the surfaces of water and beverage containers, and the machinery and facilities for the bottling of liquids.
    Type: Application
    Filed: September 16, 2011
    Publication date: March 22, 2012
    Applicant: University of Georgia Research Foundation, Inc.
    Inventors: Michael P. Doyle, Tong Zhao
  • Publication number: 20120071424
    Abstract: Disclosed is a novel use of phytosphingosine. More particularly, disclosed are a composition for preventing or treating hyper-proliferative skin diseases comprising pachastrissamine as an active ingredient, a use of pachastrissamine or a pharmaceutically acceptable salt thereof for preparing a preventing/therapeutic agent of hyper-proliferative skin diseases, and a method for treating hyper-proliferative skin diseases administering an effective amount of pachastrissamine or a pharmaceutically acceptable salt thereof to a subject in need thereof. The pachastrissamine inhibits the degradation of FoxO3a protein and increases the expression of FoxO3a protein. Thus, the inventive pharmaceutical composition has a preventing of treating effect on hyper-proliferative diseases by inducing apoptosis of hyper-proliferative cells and inhibiting the cell cycle.
    Type: Application
    Filed: September 19, 2011
    Publication date: March 22, 2012
    Applicant: Catholic University Industry Academy Cooperation Foundation
    Inventors: Dong Heon Shin, Tae Yoon Kim
  • Publication number: 20120068558
    Abstract: Disclosed is a hybrid pole bearingless switched reluctance motor (BLSRM). The BLSRM includes a stator provided with windings, a rotor rotating about an axis when current is conducted to the windings. The rotor includes a plurality of rotor poles extending radially outward, and the stator includes a plurality of stator poles extending radially inward. The windings include suspending windings to generate radial force for the rotor and torque windings to generate torque. The suspending windings are mutually separated from the torque windings. Through the use of the hybrid pole BLSRM, a stator pole generating the radial force can be controlled independently from the stator pole generating the torque by separately arranging the stator pole generating the radial force and the stator pole generating torque based on the analysis of radial force and torque characteristics according to the position of the stator poles.
    Type: Application
    Filed: July 14, 2009
    Publication date: March 22, 2012
    Applicant: Kyungsung University Industry Cooperation Foundation
    Inventors: Jin Woo Ahn, Dong Hee Lee, Huijun Wang
  • Publication number: 20120068126
    Abstract: Methods for precise and predictable modification of previously synthesized nanocrystals. The methods rely on the solubility behavior of crystalline materials to provide for controlled reversal of the nanocrystal growth process (i.e., dissolution). A method for post-synthesis modification of colloidal nanocrystals includes (1) providing a first nanocrystal having a first size and a first shape, (2) forming a reaction mixture that includes the nanocrystal, at least one ligand capable of binding to at least one component of the nanocrystal, at least one solvent, and an inert gas atmosphere, and (3) modifying the size and/or shape of the nanocrystal in the reaction mixture for a period of time at a temperature in a range from about 100 0C to about 240 0C so as to produce at least a second nanocrystal having a second size and/or a second shape.
    Type: Application
    Filed: January 20, 2010
    Publication date: March 22, 2012
    Applicant: University of Utah Research Foundation
    Inventors: Michael Bartl, Jacqueline T. Siy
  • Patent number: 8139343
    Abstract: An electrical energy storage device includes a first electrode; a second electrode; a separator; and an electrolyte; where the separator is an electronic insulator; the separator is positioned between the first and second electrodes; the separator includes a first surface proximal to the first electrode and a second surface proximal to the second electrode; the separator is configured to support an electric double layer at the first surface, the second surface, or at both the first surface and the second surface; and the device is an electrical energy storage device.
    Type: Grant
    Filed: March 7, 2011
    Date of Patent: March 20, 2012
    Assignee: WiSys Technology Foundation
    Inventors: Charles P. Gibson, Annamalai Karthikeyan
  • Patent number: 8140162
    Abstract: The invention is directed to an apparatus substantially eliminating destructive low-temperature, humidity-enhanced phase transformation of yttria-stabilized zirconia in general, as well as eliminating low-temperature degradation of yttria-stabilized tetragonal zirconia polycrystalline ceramic (Y-TZP). The martensitic-type phase transformation from tetragonal to monoclinic is accompanied by severe strength degradation in a moist environment at low-temperature, specifically at room temperature as well as at body temperature. This class of materials has been chosen as the packaging material for small implantable neural-muscular sensors and stimulators because of the high fracture toughness and high mechanical strength. This destructive phase transformation has been substantially eliminated, thus ensuring the safety of long-term implants, by subjecting the sintered components to post-machining hot isostatic pressing, such that the average grain size is less than about 0.5 microns.
    Type: Grant
    Filed: February 23, 2009
    Date of Patent: March 20, 2012
    Assignee: Alfred E. Mann Foundation For Scientific Research
    Inventors: Guangqiang Jiang, Kate E. Purnell, Gary D. Schnittgrund
  • Patent number: 8137682
    Abstract: Applicants have produced and isolated chemically cross-linked complexes of endotoxin and modified MD-2, and have developed methods of using these complexes.
    Type: Grant
    Filed: September 20, 2007
    Date of Patent: March 20, 2012
    Assignee: University of Iowa Research Foundation
    Inventors: Jerrold P. Weiss, Theresa L. Gioannini
  • Patent number: 8140170
    Abstract: An apparatus for renal neuromodulation includes an expandable support member having a main body portion for engaging a wall of a blood vessel proximate a renal vasculature and at least one electrode connected with the main body portion. The at least one electrode is arranged to selectively deliver electric current to a desired location where modulation of the sympathetic nervous system is effective to alter renal function. The apparatus further includes an insulative material attached to at least a portion of the main body portion for isolating blood flow through the vessel from the electric current delivered by the at least one electrode.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: March 20, 2012
    Assignee: The Cleveland Clinic Foundation
    Inventors: Ali R. Rezai, Roy K. Greenberg, Milind Deogaonkar
  • Patent number: 8139484
    Abstract: Provided is a traffic class of an IEEE 802.16/WiBro system. The unsolicited grant service (UGS) scheduling method with regard to a subscriber station (SS) and a base station (BS) that are disposed in a network wherein an IEEE 802.16/WiBro system is realized, the method includes: when the SS requires 1 through M (where M is a positive integer) UGS flows, and the BS serves 1 through N (where N is a positive integer) frames, the BS storing grant periods and guaranteed sizes that are granted to the M UGS flows in each N frame; and the BS comparing service capacity of a frame and a sum of guaranteed sizes of each flow belonging to the N frames, and determining if an overload occurs.
    Type: Grant
    Filed: August 28, 2008
    Date of Patent: March 20, 2012
    Assignees: Postech Academy-Industry Foundation, Posco
    Inventors: Joo-Young Baek, Min-Kon Kwak, Dong-Hee Kwon, Young Joo Suh
  • Patent number: 8137311
    Abstract: This invention relates to methods, apparatuses and systems for testing the functionality of the pumping mechanism of a medical device, e.g., an implantable infusion pump, while the medical device is contained within a shipping package. The test apparatus enables such functional verification, without opening the shipping package, when the medical device is still contained within the package that has been appropriately sealed to maintain sterility of the medical device.
    Type: Grant
    Filed: July 5, 2009
    Date of Patent: March 20, 2012
    Assignee: The Alfred E. Mann Foundation For Scientific Research
    Inventor: Stephen D. Das